Breast Cancer Survivors' Lived Experience of Adjuvant Hormone Therapy: A Thematic Analysis of Medication Side Effects and Their Impact on Adherence

被引:12
|
作者
Ibrar, Maryam [1 ]
Peddie, Nicola [1 ]
Agnew, Sommer [1 ]
Diserholt, Amanda [2 ]
Fleming, Leanne [1 ]
机构
[1] Univ Strathclyde, Sch Psychol Sci & Hlth, Glasgow, Scotland
[2] Canterbury Christ Church Univ, Sch Psychol & Life Sci, Canterbury, England
来源
FRONTIERS IN PSYCHOLOGY | 2022年 / 13卷
关键词
breast cancer; hormone therapy; lived experience; side effects; adherence; COGNITIVE-BEHAVIOR THERAPY; ENDOCRINE THERAPY; INSOMNIA; WOMEN; PERSISTENCE; DEPRESSION; RECURRENCE; TAMOXIFEN; SYMPTOMS; EFFICACY;
D O I
10.3389/fpsyg.2022.861198
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
ObjectivesSide effects from Hormone Therapy (HT) impact medication adherence in breast cancer survivors. Understanding the most distressing HT side effects and their impacts may inform the development and implementation of interventions to alleviate these side effects and maximise HT adherence. This study aimed to explore the lived experience of adjuvant HT and understand the impact of HT side effects on adherence in a sample of breast cancer survivors. MethodsTwenty-five female breast cancer survivors who were currently taking adjuvant HT participated in the study. One-to-one, online, semi-structured interviews were conducted to explore (i) specific side effects from HT and (ii) the impact of these side effects on HT adherence. Data were analysed using Thematic Analysis. ResultsThe most commonly reported side effects were sleep disturbance, hot flashes, anxiety, and joint pain. Data exploring the impacts of these side effects on HT adherence were thematically synthesised into four analytical themes: "A bitter pill to swallow," "Seeking relief," "Taking control," and "The only way out is through." These themes encompass 14 sub-themes that encapsulate participants' daily struggle with HT side effects and the coping strategies developed to manage these. ConclusionAdverse side effects from HT, such as sleep disturbance, hot flashes, pain and anxiety, impair quality of life and increase the likelihood of participants' becoming non-adherent to HT medication. In order to maximise HT adherence and reduce breast cancer mortality, HT side effects should be closely monitored to identify individuals who would benefit from targetted intervention strategies aimed at alleviating these side effects.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] A Systematic Review and Meta-Analysis of Interventions to Promote Adjuvant Endocrine Therapy Adherence Among Breast Cancer Survivors
    Bright, Emma E.
    Finkelstein, Lauren B.
    Nealis, Madeline S.
    Genung, Sarah R.
    Wrigley, Jordan
    Gu, Heng Chao J.
    Schmiege, Sarah J.
    Arch, Joanna J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (28) : 4548 - +
  • [22] Adjuvant hormonal therapy for early breast cancer: an epidemiologic study of medication adherence
    Charlotte Pourcelot
    Emeline Orillard
    Gilles Nallet
    Camille Dirand
    François Billion-Rey
    Garance Barbier
    Sarah Chouk
    Samuel Limat
    Philippe Montcuquet
    Julie Henriques
    Sophie Paget-Bailly
    Amélie Anota
    Loïc Chaigneau
    Virginie Nerich
    Breast Cancer Research and Treatment, 2018, 169 : 153 - 162
  • [23] Interventions to promote adherence to endocrine therapy among breast cancer survivors: A meta-analysis
    Finitsis, David J.
    Vose, Brittany A.
    Mahalak, Justin G.
    Salner, Andrew L.
    PSYCHO-ONCOLOGY, 2019, 28 (02) : 255 - 263
  • [24] Side-effects in women treated with adjuvant endocrine therapy for breast cancer
    Rademaker, L. M.
    Gal, R.
    May, A. M.
    Batenburg, M. C. T.
    van der Leij, F.
    Bijlsma, R. M.
    Verkooijen, H. M.
    Doeksen, A.
    Ernst, M. F.
    Evers, D. J.
    van der Pol, C. C.
    Monninkhof, E. M.
    BREAST, 2025, 80
  • [25] Systematic adaptation of the adherence improving self-management strategy to support breast cancer survivors' adherence to adjuvant endocrine therapy: An intervention mapping approach
    Janssen, Anna M.
    Dam, Joelle
    Prins, Judith
    Buffart, Laurien M.
    de Bruin, Marijn
    EUROPEAN JOURNAL OF CANCER CARE, 2022, 31 (06)
  • [26] Medication delivery factors and adjuvant endocrine therapy adherence in breast cancer
    Joan M. Neuner
    Nicole Fergestrom
    Liliana E. Pezzin
    Purushottam W. Laud
    Kathryn J. Ruddy
    Aaron N. Winn
    Breast Cancer Research and Treatment, 2023, 197 : 223 - 233
  • [27] Management of side effects related to adjuvant hormone therapy in young women with breast cancer
    Saghatchian, Mahasti
    Lesur, Anne
    BULLETIN DU CANCER, 2019, 106 (12) : S37 - S42
  • [28] Impact of web application support versus standard management on adherence with adjuvant hormone therapy in patients treated for breast cancer: the WEBAPPAC study
    François Gernier
    Jean-Michel Grellard
    Charlotte Dupont
    Hervé Castel
    Marie Fernette
    François Lahaye
    Rose-Marie Charles
    Tiphaine Leroux
    Céline Ory
    Audrey Faveyrial
    Adeline Morel
    George Emile
    Christelle Levy
    Carine Segura
    Djelila Allouache
    Alison Johnson
    Julien Geffrelot
    Katharina Gunzer
    Anaïs Lelaidier
    Gilles Girault
    Coraline Dubot-poitelon
    Chankannira San
    Justine Lequesne
    Bénédicte Clarisse
    BMC Cancer, 23 (1)
  • [29] Strategies to self-manage side-effects of adjuvant endocrine therapy among breast cancer survivors: an umbrella review of empirical evidence and clinical guidelines
    Hall, Louise H.
    King, Natalie V.
    Graham, Christopher D.
    Green, Sophie M. C.
    Barber, Alice
    Neal, Richard D.
    Foy, Robbie
    Clark, Jane
    Lloyd, Kelly E.
    Smith, Samuel G.
    JOURNAL OF CANCER SURVIVORSHIP, 2022, 16 (06) : 1296 - 1338
  • [30] Hormone therapy and osteoporosis in breast cancer survivors: assessment of risk and adherence to screening recommendations
    R. Hamood
    H. Hamood
    I. Merhasin
    L. Keinan-Boker
    Osteoporosis International, 2019, 30 : 187 - 200